| |
|
|
|
Infinity Pharmaceuticals Inc.  
|
|
1.1 0.01 (0.01%) |
09-18 16:00 |
|
Open: |
1.09 |
Pre close: |
1.09 |
Target:
|
1.42
|
|
High: |
1.1 |
Low: |
1.06 |
Resistance:
|
1.22
1.39
|
|
Volume: |
143,760 |
Market Cap: |
65M |
Support:
|
0.94
0.78
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.09
 |
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
1.09  |
Signal(12,26,9): |
0.00 |
|
MA(100): |
0.99 |
Stochastic Oscillator |
%K(14,3):
|
57.50 |
|
MA(250): |
1.06 |
%D(3): |
51.45 |
|
Average Volume(K) |
3-Month: |
91244
|
52-Week |
High:
|
1.68 |
|
10-Days: |
36856 |
Low: |
0.60 |
|
RSI |
RSI(14):
|
53.23 |
Change(%): |
-4.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.754 |
Return on Equity (ttm) |
-474.7 |
Shares Out. (M) |
58.87 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-44.4 |
Shares Float (M) |
39.35 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.51 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
40.1 |
% Held by Institutions |
50.64 |
|
Forward EPS |
-0.830 |
Gross Profit (p.s.) |
-0.533 |
Shares Short (K) |
77 |
|
Book Value (p.s.) |
-0.200 |
EBITDA (p.s.) |
-0.698 |
P/E |
-1.46 |
|
Sales Per Share |
0.024 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-5.50 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-38.04 |
P/S |
44.97 |
|
Operating Margin |
-2889.71 |
Levered Free Cash Flow
(M) |
-27.26 |
P/CF |
-1.70 |
|
|
|
|
|
|
